Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1967 1
1968 2
1969 1
1970 4
1971 4
1972 6
1973 4
1974 7
1975 2
1976 3
1977 3
1978 2
1979 4
1980 3
1981 1
1982 1
1983 1
1984 1
1985 1
1986 1
1987 1
1988 1
1990 2
1994 1
1996 1
1997 2
2000 3
2001 8
2002 5
2003 4
2004 5
2005 6
2006 5
2007 5
2008 5
2009 7
2010 10
2011 11
2012 3
2013 14
2014 7
2015 3
2016 18
2017 20
2018 15
2019 15
2020 25
2021 27
2022 31
2023 13

Text availability

Article attribute

Article type

Publication date

Search Results

291 results

Results by year

Filters applied: . Clear all
Page 1
Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism.
Haghikia A, Zimmermann F, Schumann P, Jasina A, Roessler J, Schmidt D, Heinze P, Kaisler J, Nageswaran V, Aigner A, Ceglarek U, Cineus R, Hegazy AN, van der Vorst EPC, Döring Y, Strauch CM, Nemet I, Tremaroli V, Dwibedi C, Kränkel N, Leistner DM, Heimesaat MM, Bereswill S, Rauch G, Seeland U, Soehnlein O, Müller DN, Gold R, Bäckhed F, Hazen SL, Haghikia A, Landmesser U. Haghikia A, et al. Among authors: aigner a. Eur Heart J. 2022 Feb 10;43(6):518-533. doi: 10.1093/eurheartj/ehab644. Eur Heart J. 2022. PMID: 34597388 Free PMC article. Clinical Trial.
Therapeutic siRNA: State-of-the-Art and Future Perspectives.
Friedrich M, Aigner A. Friedrich M, et al. Among authors: aigner a. BioDrugs. 2022 Sep;36(5):549-571. doi: 10.1007/s40259-022-00549-3. Epub 2022 Aug 23. BioDrugs. 2022. PMID: 35997897 Free PMC article. Review.
Nanoparticles for local delivery of siRNA in lung therapy.
Kubczak M, Michlewska S, Bryszewska M, Aigner A, Ionov M. Kubczak M, et al. Among authors: aigner a. Adv Drug Deliv Rev. 2021 Dec;179:114038. doi: 10.1016/j.addr.2021.114038. Epub 2021 Nov 3. Adv Drug Deliv Rev. 2021. PMID: 34742826 Review.
Experimental in vitro, ex vivo and in vivo models in prostate cancer research.
Sailer V, von Amsberg G, Duensing S, Kirfel J, Lieb V, Metzger E, Offermann A, Pantel K, Schuele R, Taubert H, Wach S, Perner S, Werner S, Aigner A. Sailer V, et al. Among authors: aigner a. Nat Rev Urol. 2023 Mar;20(3):158-178. doi: 10.1038/s41585-022-00677-z. Epub 2022 Nov 30. Nat Rev Urol. 2023. PMID: 36451039 Review.
Nucleic acid delivery with extracellular vesicles.
Schulz-Siegmund M, Aigner A. Schulz-Siegmund M, et al. Among authors: aigner a. Adv Drug Deliv Rev. 2021 Jun;173:89-111. doi: 10.1016/j.addr.2021.03.005. Epub 2021 Mar 19. Adv Drug Deliv Rev. 2021. PMID: 33746014 Review.
Permittivity-Asymmetric Quasi-Bound States in the Continuum.
Berté R, Weber T, de Souza Menezes L, Kühner L, Aigner A, Barkey M, Wendisch FJ, Kivshar Y, Tittl A, Maier SA. Berté R, et al. Among authors: aigner a. Nano Lett. 2023 Apr 12;23(7):2651-2658. doi: 10.1021/acs.nanolett.2c05021. Epub 2023 Mar 22. Nano Lett. 2023. PMID: 36946720
Nanoparticles for radiooncology: Mission, vision, challenges.
Kunz-Schughart LA, Dubrovska A, Peitzsch C, Ewe A, Aigner A, Schellenburg S, Muders MH, Hampel S, Cirillo G, Iemma F, Tietze R, Alexiou C, Stephan H, Zarschler K, Vittorio O, Kavallaris M, Parak WJ, Mädler L, Pokhrel S. Kunz-Schughart LA, et al. Among authors: aigner a. Biomaterials. 2017 Mar;120:155-184. doi: 10.1016/j.biomaterials.2016.12.010. Epub 2016 Dec 14. Biomaterials. 2017. PMID: 28063356 Review.
291 results